J-Lex

Dacarbazine injection 100

Dacarbazine injection 100, manufactured by Sand Pharma, contains Dacarbazine and is identified by YJ code 4219401D1031. This injectable antineoplastic agent is used in the treatment of metastatic malignant melanoma and Hodgkin’s disease, provided as a 100mg 1 bottle.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More from this manufacturer